Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera - PubMed (original) (raw)
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera
Robert Kralovics et al. Exp Hematol. 2002 Mar.
Free article
Abstract
Objective: Clonal stem cell proliferation and increased erythrocyte mass are hallmarks of the myeloproliferative disorder polycythemia vera (PV). The molecular basis of PV is unknown.
Methods: We carried out a genome-wide screening for loss of heterozygosity (LOH) and analyzed candidate genes within the LOH loci.
Results: Three genomic regions were identified on chromosomes 9p, 10q, and 11q. The presence of these LOHs in both myeloid and lymphoid cells indicated their stem cell origin. The 9pLOH prevalence is approximately 33% and is the most frequent chromosomal lesion described in PV so far. We report that the 9pLOH is due to mitotic recombination and therefore remains undetectable by cytogenetic analysis. Nineteen candidate genes were selected within the 9pLOH region for sequencing and expression analysis. No mutations were found in these genes; however, unexpectedly, increased expression of the transcription factor NFI-B was detected in granulocytes and CD34(+) cells in PV with 9pLOH. Since a member of the NFI gene family (NFI-X) was reported to result in TGF-beta resistance when overexpressed in vitro (TGF-beta is a known inhibitor of hematopoiesis), we transfected the NFI-B gene to the mouse 32D cell line. We found that overexpression of the NFI-B gene confers TGF-beta resistance in vitro.
Conclusions: We characterized a new region on chromosome 9p frequently involved in LOH in PV. Analysis of genes within this 9pLOH region revealed increased expression of the NFI-B gene. Our in vitro studies suggest that TGF-beta resistance may be the physiologic mechanism of clonal stem cell expansion in PV.
Similar articles
- A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. Kralovics R, et al. N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113. N Engl J Med. 2005. PMID: 15858187 - Acquired uniparental disomy of chromosome 9p in hematologic malignancies.
Wang L, Wheeler DA, Prchal JT. Wang L, et al. Exp Hematol. 2016 Aug;44(8):644-52. doi: 10.1016/j.exphem.2015.11.005. Epub 2015 Dec 2. Exp Hematol. 2016. PMID: 26646991 Free PMC article. Review. - Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2.
Hélias C, Struski S, Gervais C, Leymarie V, Mauvieux L, Herbrecht R, Lessard M. Hélias C, et al. Cancer Genet Cytogenet. 2008 Jan 1;180(1):51-5. doi: 10.1016/j.cancergencyto.2007.09.010. Cancer Genet Cytogenet. 2008. PMID: 18068534 - Increased expression of the INK4a/ARF locus in polycythemia vera.
Dai C, Krantz SB. Dai C, et al. Blood. 2001 Jun 1;97(11):3424-32. doi: 10.1182/blood.v97.11.3424. Blood. 2001. PMID: 11369633 - Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera.
Steidl U, Schroeder T, Steidl C, Kobbe G, Graef T, Bork S, Pechtel S, Kliszewski S, Kuendgen A, Rohr UP, Fenk R, Schroeder M, Haase D, Haas R, Kronenwett R. Steidl U, et al. Ann N Y Acad Sci. 2005 Jun;1044:94-108. doi: 10.1196/annals.1349.013. Ann N Y Acad Sci. 2005. PMID: 15958702 Review.
Cited by
- Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients.
Paes JF, Torres DG, Aquino DC, Alves EVB, Mesquita EA, Sousa MA, Fraiji NA, Passos LNM, Abreu RS, Silva GAV, Tarragô AM, de Souza Mourão LP. Paes JF, et al. Sci Rep. 2024 Apr 24;14(1):9389. doi: 10.1038/s41598-024-60090-x. Sci Rep. 2024. PMID: 38654055 Free PMC article. - Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations.
Kandarpa M, Robinson D, Wu YM, Qin T, Pettit K, Li Q, Luker G, Sartor M, Chinnaiyan A, Talpaz M. Kandarpa M, et al. Clin Cancer Res. 2024 May 1;30(9):1972-1983. doi: 10.1158/1078-0432.CCR-23-0372. Clin Cancer Res. 2024. PMID: 38386293 Free PMC article. - Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms.
Stuckey R, Bilbao-Sieyro C, Segura-Díaz A, Gómez-Casares MT. Stuckey R, et al. Int J Mol Sci. 2023 Aug 11;24(16):12700. doi: 10.3390/ijms241612700. Int J Mol Sci. 2023. PMID: 37628880 Free PMC article. Review. - Genetic basis and molecular profiling in myeloproliferative neoplasms.
Luque Paz D, Kralovics R, Skoda RC. Luque Paz D, et al. Blood. 2023 Apr 20;141(16):1909-1921. doi: 10.1182/blood.2022017578. Blood. 2023. PMID: 36347013 Free PMC article. Review. - Molecular Pathogenesis of Myeloproliferative Neoplasms.
Rolles B, Mullally A. Rolles B, et al. Curr Hematol Malig Rep. 2022 Dec;17(6):319-329. doi: 10.1007/s11899-022-00685-1. Epub 2022 Nov 7. Curr Hematol Malig Rep. 2022. PMID: 36336766 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical